Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Dubuisson

Showing results (171-180 of 241) with videos related to

Pageof 25
Sort By:
Vaccine|February 4, 2014
Neutralizing antibodies and broad, functional T cell immune response following immunization with hepatitis C virus proteins-based vaccine formulationGillian Martinez-Donato, Yalena Amador-Cañizares, Liz Alvarez-Lajonchere, et al.
Pathogens (Basel, Switzerland)|December 22, 2023
Correction: Bilyy et al. Rapid Generation of Coronaviral Immunity Using Recombinant Peptide Modified Nanodiamonds. <i>Pathogens</i> 2021, <i>10</i>, 861Rostyslav Bilyy, Quentin Pagneux, Nathan François, et al.
Hepatology (Baltimore, Md.)|January 22, 2005
Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virusDimitri Lavillette, Alexander W Tarr, Cécile Voisset, et al.
The Journal of Infectious Diseases|August 3, 2013
Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralizationSadia Anjum, Ahmed Wahid, Muhammad Sohail Afzal, et al.
Pathogens (Basel, Switzerland)|August 6, 2021
Rapid Generation of Coronaviral Immunity Using Recombinant Peptide Modified NanodiamondsRostyslav Bilyy, Quentin Pagneux, Nathan François, et al.
ACS Applied Materials & Interfaces|November 5, 2013
Phenylboronic-acid-modified nanoparticles: potential antiviral therapeuticsManakamana Khanal, Thibaut Vausselin, Alexandre Barras, et al.
The Journal of General Virology|August 16, 2005
Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsetsEriko Yamada, Maria Montoya, Christian G Schuettler, et al.
International Journal of Molecular Sciences|December 9, 2023
Discovery of Anti-Coronavirus Cinnamoyl Triterpenoids Isolated from <i>Hippophae rhamnoides</i> during a Screening of Halophytes from the North Sea and Channel Coasts in Northern FranceMalak Al Ibrahim, Zachee Louis Evariste Akissi, Lowiese Desmarets, et al.
BMC Infectious Diseases|November 7, 2019
A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in miceReham M Dawood, Rehab I Moustafa, Tawfeek H Abdelhafez, et al.
The Journal of General Virology|October 30, 2014
Regulation of core expression during the hepatitis C virus life cycleMuhammad Sohail Afzal, Khaled Alsaleh, Rayan Farhat, et al.
Pageof 25

Showing results (171-180 of 241) with videos related to

Sort By:
Pageof 25
Vaccine|February 4, 2014
Neutralizing antibodies and broad, functional T cell immune response following immunization with hepatitis C virus proteins-based vaccine formulationGillian Martinez-Donato, Yalena Amador-Cañizares, Liz Alvarez-Lajonchere, et al.
Pathogens (Basel, Switzerland)|December 22, 2023
Correction: Bilyy et al. Rapid Generation of Coronaviral Immunity Using Recombinant Peptide Modified Nanodiamonds. <i>Pathogens</i> 2021, <i>10</i>, 861Rostyslav Bilyy, Quentin Pagneux, Nathan François, et al.
Hepatology (Baltimore, Md.)|January 22, 2005
Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virusDimitri Lavillette, Alexander W Tarr, Cécile Voisset, et al.
The Journal of Infectious Diseases|August 3, 2013
Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralizationSadia Anjum, Ahmed Wahid, Muhammad Sohail Afzal, et al.
Pathogens (Basel, Switzerland)|August 6, 2021
Rapid Generation of Coronaviral Immunity Using Recombinant Peptide Modified NanodiamondsRostyslav Bilyy, Quentin Pagneux, Nathan François, et al.
ACS Applied Materials & Interfaces|November 5, 2013
Phenylboronic-acid-modified nanoparticles: potential antiviral therapeuticsManakamana Khanal, Thibaut Vausselin, Alexandre Barras, et al.
The Journal of General Virology|August 16, 2005
Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsetsEriko Yamada, Maria Montoya, Christian G Schuettler, et al.
International Journal of Molecular Sciences|December 9, 2023
Discovery of Anti-Coronavirus Cinnamoyl Triterpenoids Isolated from <i>Hippophae rhamnoides</i> during a Screening of Halophytes from the North Sea and Channel Coasts in Northern FranceMalak Al Ibrahim, Zachee Louis Evariste Akissi, Lowiese Desmarets, et al.
BMC Infectious Diseases|November 7, 2019
A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in miceReham M Dawood, Rehab I Moustafa, Tawfeek H Abdelhafez, et al.
The Journal of General Virology|October 30, 2014
Regulation of core expression during the hepatitis C virus life cycleMuhammad Sohail Afzal, Khaled Alsaleh, Rayan Farhat, et al.
Pageof 25